Global Payments To Buy Zego From Vista Equity For $925 Mln Cash

Payment technology company Global Payments Inc. (GPN) has decided to acquire property technology company Zego from Vista Equity Partners, in an all cash transaction valued at $925 million, the company said in a statement.

The effective purchase price, excluding a tax asset, is about $830 million.

"This acquisition aligns perfectly with Global Payments' strategy by enhancing our position at the convergence of software and payments in one of the largest and most attractive vertical markets worldwide, where digital commerce and omni-channel trends are rapidly accelerating," said Cameron Bready, Global Payments President and Chief Operating Officer.

Zego's solutions support property managers and residents throughout the real estate lifecycle, from leasing and onboarding to one-time and recurring payments, work orders, utility management, resident communications, renewals, and offboarding.

Zego's real estate technology platform is being used by nearly 7,000 property management customers representing more than 11 million residential units in the United States. Through its integrated payments offering, Zego facilitates nearly $30 billion in payments, a year, in a market with volume opportunity exceeds $1 trillion, Global Payments said.

The deal is expected to close by the end of the second quarter of 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hedge-fund billionaire William Ackman's Pershing Square Tontine Holdings Ltd. (PSTH) agreed to acquire 10% of Universal Music Group from French media conglomerate Vivendi (VIV.L, VIVEF.PK) for about $4 billion, the companies said in a statement on Sunday. The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings.
Follow RTT